Caris Life Sciences, Inc.

CAINASDAQHealthcareBiotechnology

$30.56- (-)1Y +0.83%

As of Oct 16, 2026 close

Market cap: $8.98B
P/E (TTM): 85.87
Forward P/E: -
Dividend yield: -
52-week range: $14.19$33.65
Volume (live): -
Avg. volume (3M): 4.72M

Caris Life Sciences, Inc. (CAI) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Caris Life Sciences, Inc. stock.

Analyst Consensus Rating

Investment consensus from 10 professional research analysts

Consensus Rating

Buy

Based on 10 unique analysts

(12 total ratings in last 90 days)

High Confidence∞:1 Buy/Sell

Average Price Target

$30.11

−1.47% downside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest CAI Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Oct 14, 2026	Casey Woodring	JP Morgan	Maintains	Buy	$25.00 → $35.00 +10.00 (+40.0%)
Oct 13, 2026	Daniel Brennan	TD Cowen	Maintains	Buy	$30.00 → $36.00 +6.00 (+20.0%)
Oct 9, 2026	Michael Ryskin	BofA Securities	Maintains	Buy	$23.00 → $35.00 +12.00 (+52.2%)
Sep 21, 2026	Evie Koslosky	Goldman Sachs	Maintains	Buy	$27.00 → $35.00 +8.00 (+29.6%)
Sep 16, 2026	Zacks Equity Research	Zacks Equity Research	Initiates Coverage	Hold	-
Sep 9, 2026	Unknown Analyst	UBS	Initiates	Hold	$28.00
Aug 7, 2026	Mark Massaro	BTIG	Reiterates	Buy	$32.00 → $33.00 +1.00 (+3.1%)
Aug 6, 2026	Kyle Mikson CFA	Canaccord Genuity	Reiterates	Hold	$22.00
Aug 6, 2026	David Westenberg	Piper Sandler	Maintains	Hold	$21.00
Aug 6, 2026	Michael Ryskin	BofA Securities	Maintains	Buy	-
Aug 6, 2026	Casey Woodring	JP Morgan	Maintains	Buy	$25.00
Aug 6, 2026	Vijay Kumar	Evercore ISI Group	Maintains	Buy	$25.00 → $26.00 +1.00 (+4.0%)

Casey Woodring

JP Morgan

BuyMaintains

$25.00 → $35.00

Oct 14

Daniel Brennan

TD Cowen

BuyMaintains

$30.00 → $36.00

Oct 13

Michael Ryskin

BofA Securities

BuyMaintains

$23.00 → $35.00

Oct 9

Evie Koslosky

Goldman Sachs

BuyMaintains

$27.00 → $35.00

Sep 21

Zacks Equity Research

HoldInitiates Coverage

Sep 16

Unknown Analyst

UBS

HoldInitiates

$28.00

Sep 9

Mark Massaro

BTIG

BuyReiterates

$32.00 → $33.00

Aug 7

Kyle Mikson CFA

Canaccord Genuity

HoldReiterates

$22.00

Aug 6

David Westenberg

Piper Sandler

HoldMaintains

$21.00

Aug 6

Michael Ryskin

BofA Securities

BuyMaintains

Aug 6

Casey Woodring

JP Morgan

BuyMaintains

$25.00

Aug 6

Vijay Kumar

Evercore ISI Group

BuyMaintains

$25.00 → $26.00

Aug 6

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 14, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for CAI?

The analyst consensus rating for CAI is Buy, based on the latest ratings from 10 analysts over the last 90 days.

What is the average price target for CAI?

The average 12-month price target for CAI is $30.11, representing a downside of 1.5% from the Oct 16, 2026 close of $30.56.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.